Red Flags Detected

  • Going Concern (worsened) — Going-concern doubt persists; cash runway shortened from $21.5M to $1.8M, now under 12 months despite Factor credit line.
NASDAQ: TPST Tempest Therapeutics, Inc. 10-Q

Tempest cash drops to $1.8M; Factor credit line uncertain, strategic-sale process removed

Filed May 14, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 25, 2026 10:10 AM